Foamable composition combining a polar solvent and a hydrophobic carrier
DCFirst Claim
1. A foamable pharmaceutical vehicle or composition, comprising:
- (1) a liquid organic carrier, at a concentration of 10% to 70% by weight of the composition, wherein said organic carrier concurrently comprises;
(i) at least one hydrophobic organic carrier comprising a triglyceride, and(ii) at least one polar solvent comprising dimethyl isosorbide,(2) a surface-active agent selected from the group consisting of at least one non-ionic surface-active agent, and a mixture of a non-ionic surface-active agent and an ionic surface-active agent, wherein the ratio of non-ionic surface-active agent to ionic surface-active agent is greater than 14;
1;
(3) water;
(4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition; and
(5) a polymeric agent selected from the group consisting of a locust bean gum, sodium caseinate, an egg albumin, a gelatin agar, a carrageenin gum, sodium alginate, a xanthan gum, a quince seed extract, a tragacanth gum, a guar gum, a starch, a chemically modified starch, a cellulose ether, an alkyl cellulose, a hydroxyalkyl cellulose, a hydroxyethyl cellulose, a hydroxypropyl cellulose, a methyl cellulose, a carboxymethyl cellulose, a methylhydroxyethylcellulose, a methylhydroxypropylcellulose, a hydroxypropylmethyl cellulose, a hydroxyethylcarboxymethylcellulose, a carboxymethylhydroxyethylcellulose, a hydroxypropyl guar gum, a soluble starch, a carboxyvinyl polymer, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyacrylic acid polymer, a polymethacrylic acid polymer, a polyvinyl acetate polymer, a polyvinyl chloride polymer, a polyvinylidene chloride polymer, an acrylic acid/ethyl acrylate copolymer, a carboxyvinyl polymer, a silicone dioxide, a poly(acrylic)acid, a poly(methylvinyl ether/maleic anhydride) copolymer, a chitosan, an alginic acid, a hyaluronic acid, a pectin, a karaya gum, a cyclodextrin, a chemically modified cyclodextrin, hydroxypropyl-β
-cyclodextrin, a poly(N-isopropylamide), a poloxamer, and mixtures of any two or more thereof; and
wherein the composition is provided in an aerosol container and upon release expands to form a breakable foam that collapses upon application of shear force.
8 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention relates to a foamable vehicle or cosmetic or pharmaceutical composition, comprising: (1) an organic carrier, at a concentration of 10% to 70% by weight, wherein said organic carrier concurrently comprises: (i) at least one hydrophobic organic carrier, and (ii) at least one polar solvent; (2) at least one surface-active agent; (3) water; and (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition.
The present invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject, comprising administering the above-mentioned compositions to an afflicted target site.
1026 Citations
67 Claims
-
1. A foamable pharmaceutical vehicle or composition, comprising:
-
(1) a liquid organic carrier, at a concentration of 10% to 70% by weight of the composition, wherein said organic carrier concurrently comprises; (i) at least one hydrophobic organic carrier comprising a triglyceride, and (ii) at least one polar solvent comprising dimethyl isosorbide, (2) a surface-active agent selected from the group consisting of at least one non-ionic surface-active agent, and a mixture of a non-ionic surface-active agent and an ionic surface-active agent, wherein the ratio of non-ionic surface-active agent to ionic surface-active agent is greater than 14;
1;(3) water; (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition; and (5) a polymeric agent selected from the group consisting of a locust bean gum, sodium caseinate, an egg albumin, a gelatin agar, a carrageenin gum, sodium alginate, a xanthan gum, a quince seed extract, a tragacanth gum, a guar gum, a starch, a chemically modified starch, a cellulose ether, an alkyl cellulose, a hydroxyalkyl cellulose, a hydroxyethyl cellulose, a hydroxypropyl cellulose, a methyl cellulose, a carboxymethyl cellulose, a methylhydroxyethylcellulose, a methylhydroxypropylcellulose, a hydroxypropylmethyl cellulose, a hydroxyethylcarboxymethylcellulose, a carboxymethylhydroxyethylcellulose, a hydroxypropyl guar gum, a soluble starch, a carboxyvinyl polymer, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyacrylic acid polymer, a polymethacrylic acid polymer, a polyvinyl acetate polymer, a polyvinyl chloride polymer, a polyvinylidene chloride polymer, an acrylic acid/ethyl acrylate copolymer, a carboxyvinyl polymer, a silicone dioxide, a poly(acrylic)acid, a poly(methylvinyl ether/maleic anhydride) copolymer, a chitosan, an alginic acid, a hyaluronic acid, a pectin, a karaya gum, a cyclodextrin, a chemically modified cyclodextrin, hydroxypropyl-β
-cyclodextrin, a poly(N-isopropylamide), a poloxamer, and mixtures of any two or more thereof; andwherein the composition is provided in an aerosol container and upon release expands to form a breakable foam that collapses upon application of shear force. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 33, 34, 35, 36, 37, 38, 39, 42, 43, 44, 45, 46, 47, 54, 55, 58, 62, 63, 64, 65, 66)
-
-
20. A method of treating or alleviating a disorder selected from the group consisting of acne, an infection, an inflammation, psoriasis, and rosacea, comprising:
-
administering topically to a surface having the disorder, a foamed composition obtained from a canister comprising a foamable composition comprising; (1) a liquid organic carrier, at a concentration of 10% to 70% by weight of the foamable composition, wherein said organic carrier concurrently comprises; i. at least one hydrophobic organic carrier comprising a triglyceride, and ii. at least one polar solvent comprising dimethyl isosorbide; (2) 0.1% to 5% by weight of the foamable composition of a surface-active agent selected from the group consisting of at least one non-ionic surface-active agent, and a mixture of a non-ionic surface-active agent and an ionic surface-active agent, wherein the ratio of non-ionic surface-active agent to ionic surface-active agent is greater than 14;
1;(3) water; (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition; (5) a polymeric agent selected from the group consisting of a locust bean gum, sodium caseinate, an egg albumin, a gelatin agar, a carrageenin gum, sodium alginate, a xanthan gum, a quince seed extract, a tragacanth gum, a guar gum, a starch, a chemically modified starch, a cellulose ether, an alkyl cellulose, a hydroxyalkyl cellulose, a hydroxyethyl cellulose, a hydroxypropyl cellulose, a methyl cellulose, a carboxymethyl cellulose, a methylhydroxyethylcellulose, a methylhydroxypropylcellulose, a hydroxypropylmethyl cellulose, a hydroxyethylcarboxymethylcellulose, a carboxymethylhydroxyethylcellulose, a hydroxypropyl guar gum, a soluble starch, a carboxyvinyl polymer, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyacrylic acid polymer, a polymethacrylic acid polymer, a polyvinyl acetate polymer, a polyvinyl chloride polymer, a polyvinylidene chloride polymer, an acrylic acid/ethyl acrylate copolymer, a carboxyvinyl polymer, a silicone dioxide, a poly(acrylic)acid, a poly(methylvinyl ether/maleic anhydride) copolymer, a chitosan, an alginic acid, a hyaluronic acid, a pectin, a karaya gum, a cyclodextrin, a chemically modified cyclodextrin, hydroxypropyl-β
-cyclodextrin, a poly(N-isopropylamide), a poloxamer, and mixtures of any two or more thereof; and(6) an active agent; and wherein the composition is provided in an aerosol container and upon release expands to form a breakable foam that collapses upon application of shear force. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28, 29, 41, 48, 49, 50, 51, 52, 53, 56, 57, 67)
-
-
30. A non-flammable foamable pharmaceutical composition comprising:
-
(1) a liquid organic carrier, at a concentration of 10% to 70% by weight of the pharmaceutical composition, wherein said organic carrier contains at least one member selected from the group consisting of; (i) at least one hydrophobic organic carrier comprising a triglyceride, and (ii) at least one polar solvent comprising dimethyl isosorbide and a diol; (2) a surface-active agent selected from the group consisting of at least one non-ionic surface-active agent, and a mixture of a non-ionic surface-active agent and an ionic surface-active agent, wherein the ratio of non-ionic surface-active agent to ionic surface-active agent is greater than 14;
1;(3) water; (4) at least one hydrofluorocarbon propellant at a concentration of 3% to 25% by weight of the total composition; and (5) a polymeric agent selected from the group consisting of a locust bean gum, sodium caseinate, an egg albumin, a gelatin agar, a carrageenin gum, sodium alginate, a xanthan gum, a quince seed extract, a tragacanth gum, a guar gum, a starch, a chemically modified starch, a cellulose ether, an alkyl cellulose, a hydroxyalkyl cellulose, a hydroxyethyl cellulose, a hydroxypropyl cellulose, a methyl cellulose, a carboxymethyl cellulose, a methylhydroxyethylcellulose, a methylhydroxypropylcellulose, a hydroxypropylmethyl cellulose, a hydroxyethylcarboxymethylcellulose, a carboxymethylhydroxyethylcellulose, a hydroxypropyl guar gum, a soluble starch, a carboxyvinyl polymer, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyacrylic acid polymer, a polymethacrylic acid polymer, a polyvinyl acetate polymer, a polyvinyl chloride polymer, a polyvinylidene chloride polymer, an acrylic acid/ethyl acrylate copolymer, a carboxyvinyl polymer, a silicone dioxide, a poly(acrylic)acid, a poly(methylvinyl ether/maleic anhydride) copolymer, a chitosan, an alginic acid, a hyaluronic acid, a pectin, a karaya gum, a cyclodextrin, a chemically modified cyclodextrin, hydroxypropyl-β
-cyclodextrin, a poly(N-isopropylamide), a poloxamer, and mixtures of any two or more thereof; andwherein the composition is provided in an aerosol container and upon release expands to form a breakable foam that collapses upon application of shear force. - View Dependent Claims (31, 32, 40, 59, 60, 61)
-
Specification